APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Receptor ROR Gamma

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nuclear Receptor ROR Gamma Market Analysis and Forecast 2026-2032

19 December 2025205 pages

Choose your research edition.

Industry ResearchNuclear Receptor ROR Gamma Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Receptor ROR Gamma Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Nuclear Receptor ROR Gamma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Receptor ROR Gamma Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Receptor ROR Gamma Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Nuclear Receptor ROR Gamma market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nuclear Receptor ROR Gamma is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nuclear Receptor ROR Gamma is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nuclear Receptor ROR Gamma is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nuclear Receptor ROR Gamma is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nuclear Receptor ROR Gamma include Eli Lilly, GlaxoSmithKline Plc, Biogen Inc, Beijing Hanmi Pharmaceutical, Reata Pharmaceuticals Inc, Phenex Pharmaceuticals AG, Pfizer Inc, Lead Pharma Holding BV and Glenmark Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nuclear Receptor ROR Gamma, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nuclear Receptor ROR Gamma, also provides the sales of main regions and countries. Of the upcoming market potential for Nuclear Receptor ROR Gamma, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nuclear Receptor ROR Gamma sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nuclear Receptor ROR Gamma market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nuclear Receptor ROR Gamma sales, projected growth trends, production technology, application and end-user industry.

Nuclear Receptor ROR Gamma Segment by Company

Eli Lilly

GlaxoSmithKline Plc

Biogen Inc

Beijing Hanmi Pharmaceutical

Reata Pharmaceuticals Inc

Phenex Pharmaceuticals AG

Pfizer Inc

Lead Pharma Holding BV

Glenmark Pharmaceuticals

Genfit SA

Eurofins Advinus

Celgene Corp

Bristol-Myers Squibb Company

Brickell Biotech Inc

Aurigene Discovery Technologies

AbbVie Inc

Nuclear Receptor ROR Gamma Segment by Type

BBI-6000

R&D Progress

INV-17

IMU-366

GSK-2981278

GRC-39815Action

Others

Nuclear Receptor ROR Gamma Segment by Application

Axial Spondyloarthritis

Asthma

Breast Cancer

Chronic Obstructive Pulmonary Disease

Others

Nuclear Receptor ROR Gamma Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Receptor ROR Gamma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Receptor ROR Gamma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Receptor ROR Gamma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nuclear Receptor ROR Gamma in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nuclear Receptor ROR Gamma manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Receptor ROR Gamma sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nuclear Receptor ROR Gamma Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. BBI-6000 Major Manufacturers Table 3. R&D Progress Major Manufacturers Table 4. INV-17 Major Manufacturers Table 5. IMU-366 Major Manufacturers Table 6. GSK-2981278 Major Manufacturers Table 7. GRC-39815Action Major Manufacturers Table 8. Others Major Manufacturers Table 9. Global Nuclear Receptor ROR Gamma Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Axial Spondyloarthritis Major Manufacturers Table 11. Asthma Major Manufacturers Table 12. Breast Cancer Major Manufacturers Table 13. Chronic Obstructive Pulmonary Disease Major Manufacturers Table 14. Others Major Manufacturers Table 15. Nuclear Receptor ROR Gamma Industry Trends Table 16. Nuclear Receptor ROR Gamma Industry Drivers Table 17. Nuclear Receptor ROR Gamma Industry Opportunities and Challenges Table 18. Nuclear Receptor ROR Gamma Industry Restraints Table 19. Global Nuclear Receptor ROR Gamma Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Nuclear Receptor ROR Gamma Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Nuclear Receptor ROR Gamma Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2021-2026) Table 23. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2027-2032) Table 24. Global Nuclear Receptor ROR Gamma Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 25. Global Nuclear Receptor ROR Gamma Sales by Region (2021-2026) & (W Units) Table 26. Global Nuclear Receptor ROR Gamma Sales by Region (2027-2032) & (W Units) Table 27. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2021-2026) Table 28. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2027-2032) Table 29. Global Nuclear Receptor ROR Gamma Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Nuclear Receptor ROR Gamma Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Nuclear Receptor ROR Gamma Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Nuclear Receptor ROR Gamma Sales Market Share by Manufacturers (2021-2026) Table 33. Global Nuclear Receptor ROR Gamma Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 34. Global Nuclear Receptor ROR Gamma Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Nuclear Receptor ROR Gamma Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Nuclear Receptor ROR Gamma Manufacturers, Product Type & Application Table 37. Global Nuclear Receptor ROR Gamma Manufacturers' Establishment Date Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Nuclear Receptor ROR Gamma by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Nuclear Receptor ROR Gamma Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Nuclear Receptor ROR Gamma Revenue by Type (2021-2026) & (US$ Million) Table 42. Global Nuclear Receptor ROR Gamma Revenue by Type (2027-2032) & (US$ Million) Table 43. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2021-2026) Table 44. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2027-2032) Table 45. Global Nuclear Receptor ROR Gamma Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 46. Global Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (W Units) Table 47. Global Nuclear Receptor ROR Gamma Sales by Type (2027-2032) & (W Units) Table 48. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2021-2026) Table 49. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2027-2032) Table 50. Global Nuclear Receptor ROR Gamma Price by Type (2021-2026) & (US$/Unit) Table 51. Global Nuclear Receptor ROR Gamma Price by Type (2027-2032) & (US$/Unit) Table 52. Global Nuclear Receptor ROR Gamma Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Nuclear Receptor ROR Gamma Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Nuclear Receptor ROR Gamma Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2021-2026) Table 56. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2027-2032) Table 57. Global Nuclear Receptor ROR Gamma Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 58. Global Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (W Units) Table 59. Global Nuclear Receptor ROR Gamma Sales by Application (2027-2032) & (W Units) Table 60. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2021-2026) Table 61. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2027-2032) Table 62. Global Nuclear Receptor ROR Gamma Price by Application (2021-2026) & (US$/Unit) Table 63. Global Nuclear Receptor ROR Gamma Price by Application (2027-2032) & (US$/Unit) Table 64. Eli Lilly Company Information Table 65. Eli Lilly Business Overview Table 66. Eli Lilly Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Eli Lilly Nuclear Receptor ROR Gamma Product Portfolio Table 68. Eli Lilly Recent Development Table 69. GlaxoSmithKline Plc Company Information Table 70. GlaxoSmithKline Plc Business Overview Table 71. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product Portfolio Table 73. GlaxoSmithKline Plc Recent Development Table 74. Biogen Inc Company Information Table 75. Biogen Inc Business Overview Table 76. Biogen Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Biogen Inc Nuclear Receptor ROR Gamma Product Portfolio Table 78. Biogen Inc Recent Development Table 79. Beijing Hanmi Pharmaceutical Company Information Table 80. Beijing Hanmi Pharmaceutical Business Overview Table 81. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product Portfolio Table 83. Beijing Hanmi Pharmaceutical Recent Development Table 84. Reata Pharmaceuticals Inc Company Information Table 85. Reata Pharmaceuticals Inc Business Overview Table 86. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product Portfolio Table 88. Reata Pharmaceuticals Inc Recent Development Table 89. Phenex Pharmaceuticals AG Company Information Table 90. Phenex Pharmaceuticals AG Business Overview Table 91. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product Portfolio Table 93. Phenex Pharmaceuticals AG Recent Development Table 94. Pfizer Inc Company Information Table 95. Pfizer Inc Business Overview Table 96. Pfizer Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Pfizer Inc Nuclear Receptor ROR Gamma Product Portfolio Table 98. Pfizer Inc Recent Development Table 99. Lead Pharma Holding BV Company Information Table 100. Lead Pharma Holding BV Business Overview Table 101. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product Portfolio Table 103. Lead Pharma Holding BV Recent Development Table 104. Glenmark Pharmaceuticals Company Information Table 105. Glenmark Pharmaceuticals Business Overview Table 106. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product Portfolio Table 108. Glenmark Pharmaceuticals Recent Development Table 109. Genfit SA Company Information Table 110. Genfit SA Business Overview Table 111. Genfit SA Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Genfit SA Nuclear Receptor ROR Gamma Product Portfolio Table 113. Genfit SA Recent Development Table 114. Eurofins Advinus Company Information Table 115. Eurofins Advinus Business Overview Table 116. Eurofins Advinus Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Eurofins Advinus Nuclear Receptor ROR Gamma Product Portfolio Table 118. Eurofins Advinus Recent Development Table 119. Celgene Corp Company Information Table 120. Celgene Corp Business Overview Table 121. Celgene Corp Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Celgene Corp Nuclear Receptor ROR Gamma Product Portfolio Table 123. Celgene Corp Recent Development Table 124. Bristol-Myers Squibb Company Company Information Table 125. Bristol-Myers Squibb Company Business Overview Table 126. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product Portfolio Table 128. Bristol-Myers Squibb Company Recent Development Table 129. Brickell Biotech Inc Company Information Table 130. Brickell Biotech Inc Business Overview Table 131. Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Brickell Biotech Inc Nuclear Receptor ROR Gamma Product Portfolio Table 133. Brickell Biotech Inc Recent Development Table 134. Aurigene Discovery Technologies Company Information Table 135. Aurigene Discovery Technologies Business Overview Table 136. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product Portfolio Table 138. Aurigene Discovery Technologies Recent Development Table 139. AbbVie Inc Company Information Table 140. AbbVie Inc Business Overview Table 141. AbbVie Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. AbbVie Inc Nuclear Receptor ROR Gamma Product Portfolio Table 143. AbbVie Inc Recent Development Table 144. North America Nuclear Receptor ROR Gamma Revenue by Type (2021-2026) & (US$ Million) Table 145. North America Nuclear Receptor ROR Gamma Revenue by Type (2027-2032) & (US$ Million) Table 146. North America Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (W Units) Table 147. North America Nuclear Receptor ROR Gamma Sales by Type (2027-2032) & (W Units) Table 148. North America Nuclear Receptor ROR Gamma Sales Price by Type (2021-2026) & (US$/Unit) Table 149. North America Nuclear Receptor ROR Gamma Sales Price by Type (2027-2032) & (US$/Unit) Table 150. North America Nuclear Receptor ROR Gamma Revenue by Application (2021-2026) & (US$ Million) Table 151. North America Nuclear Receptor ROR Gamma Revenue by Application (2027-2032) & (US$ Million) Table 152. North America Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (W Units) Table 153. North America Nuclear Receptor ROR Gamma Sales by Application (2027-2032) & (W Units) Table 154. North America Nuclear Receptor ROR Gamma Sales Price by Application (2021-2026) & (US$/Unit) Table 155. North America Nuclear Receptor ROR Gamma Sales Price by Application (2027-2032) & (US$/Unit) Table 156. North America Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. North America Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. North America Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. North America Nuclear Receptor ROR Gamma Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 160. North America Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 161. North America Nuclear Receptor ROR Gamma Sales by Country (2027-2032) & (W Units) Table 162. North America Nuclear Receptor ROR Gamma Sales Price by Country (2021-2026) & (US$/Unit) Table 163. North America Nuclear Receptor ROR Gamma Sales Price by Country (2027-2032) & (US$/Unit) Table 164. United States Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 165. Canada Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 166. Europe Nuclear Receptor ROR Gamma Revenue by Type (2021-2026) & (US$ Million) Table 167. Europe Nuclear Receptor ROR Gamma Revenue by Type (2027-2032) & (US$ Million) Table 168. Europe Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (W Units) Table 169. Europe Nuclear Receptor ROR Gamma Sales by Type (2027-2032) & (W Units) Table 170. Europe Nuclear Receptor ROR Gamma Sales Price by Type (2021-2026) & (US$/Unit) Table 171. Europe Nuclear Receptor ROR Gamma Sales Price by Type (2027-2032) & (US$/Unit) Table 172. Europe Nuclear Receptor ROR Gamma Revenue by Application (2021-2026) & (US$ Million) Table 173. Europe Nuclear Receptor ROR Gamma Revenue by Application (2027-2032) & (US$ Million) Table 174. Europe Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (W Units) Table 175. Europe Nuclear Receptor ROR Gamma Sales by Application (2027-2032) & (W Units) Table 176. Europe Nuclear Receptor ROR Gamma Sales Price by Application (2021-2026) & (US$/Unit) Table 177. Europe Nuclear Receptor ROR Gamma Sales Price by Application (2027-2032) & (US$/Unit) Table 178. Europe Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Europe Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Europe Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Europe Nuclear Receptor ROR Gamma Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 182. Europe Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 183. Europe Nuclear Receptor ROR Gamma Sales by Country (2027-2032) & (W Units) Table 184. Europe Nuclear Receptor ROR Gamma Sales Price by Country (2021-2026) & (US$/Unit) Table 185. Europe Nuclear Receptor ROR Gamma Sales Price by Country (2027-2032) & (US$/Unit) Table 186. Germany Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 187. France Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 188. U.K. Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 189. Italy Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 190. Netherlands Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 191. Nordic Countries Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 192. China Nuclear Receptor ROR Gamma Revenue by Type (2021-2026) & (US$ Million) Table 193. China Nuclear Receptor ROR Gamma Revenue by Type (2027-2032) & (US$ Million) Table 194. China Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (W Units) Table 195. China Nuclear Receptor ROR Gamma Sales by Type (2027-2032) & (W Units) Table 196. China Nuclear Receptor ROR Gamma Sales Price by Type (2021-2026) & (US$/Unit) Table 197. China Nuclear Receptor ROR Gamma Sales Price by Type (2027-2032) & (US$/Unit) Table 198. China Nuclear Receptor ROR Gamma Revenue by Application (2021-2026) & (US$ Million) Table 199. China Nuclear Receptor ROR Gamma Revenue by Application (2027-2032) & (US$ Million) Table 200. China Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (W Units) Table 201. China Nuclear Receptor ROR Gamma Sales by Application (2027-2032) & (W Units) Table 202. China Nuclear Receptor ROR Gamma Sales Price by Application (2021-2026) & (US$/Unit) Table 203. China Nuclear Receptor ROR Gamma Sales Price by Application (2027-2032) & (US$/Unit) Table 204. Asia Nuclear Receptor ROR Gamma Revenue by Type (2021-2026) & (US$ Million) Table 205. Asia Nuclear Receptor ROR Gamma Revenue by Type (2027-2032) & (US$ Million) Table 206. Asia Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (W Units) Table 207. Asia Nuclear Receptor ROR Gamma Sales by Type (2027-2032) & (W Units) Table 208. Asia Nuclear Receptor ROR Gamma Sales Price by Type (2021-2026) & (US$/Unit) Table 209. Asia Nuclear Receptor ROR Gamma Sales Price by Type (2027-2032) & (US$/Unit) Table 210. Asia Nuclear Receptor ROR Gamma Revenue by Application (2021-2026) & (US$ Million) Table 211. Asia Nuclear Receptor ROR Gamma Revenue by Application (2027-2032) & (US$ Million) Table 212. Asia Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (W Units) Table 213. Asia Nuclear Receptor ROR Gamma Sales by Application (2027-2032) & (W Units) Table 214. Asia Nuclear Receptor ROR Gamma Sales Price by Application (2021-2026) & (US$/Unit) Table 215. Asia Nuclear Receptor ROR Gamma Sales Price by Application (2027-2032) & (US$/Unit) Table 216. Asia Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. Asia Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. Asia Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. Asia Nuclear Receptor ROR Gamma Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 220. Asia Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 221. Asia Nuclear Receptor ROR Gamma Sales by Country (2027-2032) & (W Units) Table 222. Asia Nuclear Receptor ROR Gamma Sales Price by Country (2021-2026) & (US$/Unit) Table 223. Asia Nuclear Receptor ROR Gamma Sales Price by Country (2027-2032) & (US$/Unit) Table 224. Japan Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 225. South Korea Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 226. India Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 227. Australia Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 228. China Taiwan Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 229. Southeast Asia Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 230. SAMEA Nuclear Receptor ROR Gamma Revenue by Type (2021-2026) & (US$ Million) Table 231. SAMEA Nuclear Receptor ROR Gamma Revenue by Type (2027-2032) & (US$ Million) Table 232. SAMEA Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (W Units) Table 233. SAMEA Nuclear Receptor ROR Gamma Sales by Type (2027-2032) & (W Units) Table 234. SAMEA Nuclear Receptor ROR Gamma Sales Price by Type (2021-2026) & (US$/Unit) Table 235. SAMEA Nuclear Receptor ROR Gamma Sales Price by Type (2027-2032) & (US$/Unit) Table 236. SAMEA Nuclear Receptor ROR Gamma Revenue by Application (2021-2026) & (US$ Million) Table 237. SAMEA Nuclear Receptor ROR Gamma Revenue by Application (2027-2032) & (US$ Million) Table 238. SAMEA Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (W Units) Table 239. SAMEA Nuclear Receptor ROR Gamma Sales by Application (2027-2032) & (W Units) Table 240. SAMEA Nuclear Receptor ROR Gamma Sales Price by Application (2021-2026) & (US$/Unit) Table 241. SAMEA Nuclear Receptor ROR Gamma Sales Price by Application (2027-2032) & (US$/Unit) Table 242. SAMEA Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 243. SAMEA Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 244. SAMEA Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 245. SAMEA Nuclear Receptor ROR Gamma Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 246. SAMEA Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 247. SAMEA Nuclear Receptor ROR Gamma Sales by Country (2027-2032) & (W Units) Table 248. SAMEA Nuclear Receptor ROR Gamma Sales Price by Country (2021-2026) & (US$/Unit) Table 249. SAMEA Nuclear Receptor ROR Gamma Sales Price by Country (2027-2032) & (US$/Unit) Table 250. Brazil Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 251. Argentina Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 252. Chile Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 253. Colombia Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 254. Peru Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 255. Saudi Arabia Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 256. Israel Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 257. UAE Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 258. Turkey Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 259. Iran Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 260. Egypt Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Table 261. Key Raw Materials Table 262. Raw Materials Key Suppliers Table 263. Nuclear Receptor ROR Gamma Distributors List Table 264. Nuclear Receptor ROR Gamma Customers List Table 265. Research Programs/Design for This Report Table 266. Authors List of This Report Table 267. Secondary Sources Table 268. Primary Sources List of Figures Figure 1. Nuclear Receptor ROR Gamma Image Figure 2. Global Nuclear Receptor ROR Gamma Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nuclear Receptor ROR Gamma Market Size Share 2021 VS 2025 VS 2032 Figure 4. BBI-6000 Image Figure 5. R&D Progress Image Figure 6. INV-17 Image Figure 7. IMU-366 Image Figure 8. GSK-2981278 Image Figure 9. GRC-39815Action Image Figure 10. Others Image Figure 11. Global Nuclear Receptor ROR Gamma Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Nuclear Receptor ROR Gamma Market Size Share 2021 VS 2025 VS 2032 Figure 13. Axial Spondyloarthritis Image Figure 14. Asthma Image Figure 15. Breast Cancer Image Figure 16. Chronic Obstructive Pulmonary Disease Image Figure 17. Others Image Figure 18. Global Nuclear Receptor ROR Gamma Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Figure 20. Global Nuclear Receptor ROR Gamma Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region: 2025 Versus 2032 Figure 22. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2021-2032) Figure 23. Global Nuclear Receptor ROR Gamma Sales (2021-2032) & (W Units) Figure 24. Global Nuclear Receptor ROR Gamma Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 25. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2021-2032) Figure 26. US & Canada & Mexico Nuclear Receptor ROR Gamma Sales YoY (2021-2032) & (W Units) Figure 27. Europe Nuclear Receptor ROR Gamma Sales YoY (2021-2032) & (W Units) Figure 28. China Nuclear Receptor ROR Gamma Sales YoY (2021-2032) & (W Units) Figure 29. Asia (Excluding China) Nuclear Receptor ROR Gamma Sales YoY (2021-2032) & (W Units) Figure 30. South America, Middle East and Africa Nuclear Receptor ROR Gamma Sales YoY (2021-2032) & (W Units) Figure 31. Global Nuclear Receptor ROR Gamma Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 32. Global Nuclear Receptor ROR Gamma Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. Global Nuclear Receptor ROR Gamma Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2021-2032) Figure 37. Global Nuclear Receptor ROR Gamma Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 38. Global Nuclear Receptor ROR Gamma Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 39. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2021-2032) Figure 40. Global Nuclear Receptor ROR Gamma Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 41. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2021-2032) Figure 43. Global Nuclear Receptor ROR Gamma Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 44. Global Nuclear Receptor ROR Gamma Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 45. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2021-2032) Figure 46. North America Nuclear Receptor ROR Gamma Revenue Share by Type (2021-2032) Figure 47. North America Nuclear Receptor ROR Gamma Sales Share by Type (2021-2032) Figure 48. North America Nuclear Receptor ROR Gamma Revenue Share by Application (2021-2032) Figure 49. North America Nuclear Receptor ROR Gamma Sales Share by Application (2021-2032) Figure 50. North America Nuclear Receptor ROR Gamma Revenue Share by Country (2021-2032) Figure 51. North America Nuclear Receptor ROR Gamma Sales Share by Country (2021-2032) Figure 52. Europe Nuclear Receptor ROR Gamma Revenue Share by Type (2021-2032) Figure 53. Europe Nuclear Receptor ROR Gamma Sales Share by Type (2021-2032) Figure 54. Europe Nuclear Receptor ROR Gamma Revenue Share by Application (2021-2032) Figure 55. Europe Nuclear Receptor ROR Gamma Sales Share by Application (2021-2032) Figure 56. Europe Nuclear Receptor ROR Gamma Revenue Share by Country (2021-2032) Figure 57. Europe Nuclear Receptor ROR Gamma Sales Share by Country (2021-2032) Figure 58. China Nuclear Receptor ROR Gamma Revenue Share by Type (2021-2032) Figure 59. China Nuclear Receptor ROR Gamma Sales Share by Type (2021-2032) Figure 60. China Nuclear Receptor ROR Gamma Revenue Share by Application (2021-2032) Figure 61. China Nuclear Receptor ROR Gamma Sales Share by Application (2021-2032) Figure 62. Asia Nuclear Receptor ROR Gamma Revenue Share by Type (2021-2032) Figure 63. Asia Nuclear Receptor ROR Gamma Sales Share by Type (2021-2032) Figure 64. Asia Nuclear Receptor ROR Gamma Revenue Share by Application (2021-2032) Figure 65. Asia Nuclear Receptor ROR Gamma Sales Share by Application (2021-2032) Figure 66. Asia Nuclear Receptor ROR Gamma Revenue Share by Country (2021-2032) Figure 67. Asia Nuclear Receptor ROR Gamma Sales Share by Country (2021-2032) Figure 68. SAMEA Nuclear Receptor ROR Gamma Revenue Share by Type (2021-2032) Figure 69. SAMEA Nuclear Receptor ROR Gamma Sales Share by Type (2021-2032) Figure 70. SAMEA Nuclear Receptor ROR Gamma Revenue Share by Application (2021-2032) Figure 71. SAMEA Nuclear Receptor ROR Gamma Sales Share by Application (2021-2032) Figure 72. SAMEA Nuclear Receptor ROR Gamma Revenue Share by Country (2021-2032) Figure 73. SAMEA Nuclear Receptor ROR Gamma Sales Share by Country (2021-2032) Figure 74. Nuclear Receptor ROR Gamma Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Nuclear Receptor ROR Gamma Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • BBI-6000
  • R&D Progress
  • INV-17
  • IMU-366
  • GSK-2981278
  • GRC-39815Action
  • Others
Applications
  • Axial Spondyloarthritis
  • Asthma
  • Breast Cancer
  • Chronic Obstructive Pulmonary Disease
  • Others
Companies covered
  • Eli Lilly
  • GlaxoSmithKline Plc
  • Biogen Inc
  • Beijing Hanmi Pharmaceutical
  • Reata Pharmaceuticals Inc
  • Phenex Pharmaceuticals AG
  • Pfizer Inc
  • Lead Pharma Holding BV
  • Glenmark Pharmaceuticals
  • Genfit SA
  • Eurofins Advinus
  • Celgene Corp
  • Bristol-Myers Squibb Company
  • Brickell Biotech Inc
  • Aurigene Discovery Technologies
  • AbbVie Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nuclear Receptor ROR Gamma Market by Type
  3. 1.2.1 Global Nuclear Receptor ROR Gamma Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 BBI-6000
  5. 1.2.3 R&D Progress
  6. 1.2.4 INV-17
  7. 1.2.5 IMU-366
  8. 1.2.6 GSK-2981278
  9. 1.2.7 GRC-39815Action
  10. 1.2.8 Others
  11. 1.3 Nuclear Receptor ROR Gamma Market by Application
  12. 1.3.1 Global Nuclear Receptor ROR Gamma Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Axial Spondyloarthritis
  14. 1.3.3 Asthma
  15. 1.3.4 Breast Cancer
  16. 1.3.5 Chronic Obstructive Pulmonary Disease
  17. 1.3.6 Others
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Nuclear Receptor ROR Gamma Market Dynamics
  1. 2.1 Nuclear Receptor ROR Gamma Industry Trends
  2. 2.2 Nuclear Receptor ROR Gamma Industry Drivers
  3. 2.3 Nuclear Receptor ROR Gamma Industry Opportunities and Challenges
  4. 2.4 Nuclear Receptor ROR Gamma Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nuclear Receptor ROR Gamma Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nuclear Receptor ROR Gamma Revenue by Region
  3. 3.2.1 Global Nuclear Receptor ROR Gamma Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nuclear Receptor ROR Gamma Revenue by Region (2021-2026)
  5. 3.2.3 Global Nuclear Receptor ROR Gamma Revenue by Region (2027-2032)
  6. 3.2.4 Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nuclear Receptor ROR Gamma Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nuclear Receptor ROR Gamma Sales by Region
  9. 3.4.1 Global Nuclear Receptor ROR Gamma Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nuclear Receptor ROR Gamma Sales by Region (2021-2026)
  11. 3.4.3 Global Nuclear Receptor ROR Gamma Sales by Region (2027-2032)
  12. 3.4.4 Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nuclear Receptor ROR Gamma Revenue by Manufacturers
  2. 4.1.1 Global Nuclear Receptor ROR Gamma Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nuclear Receptor ROR Gamma Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nuclear Receptor ROR Gamma Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nuclear Receptor ROR Gamma Sales by Manufacturers
  6. 4.2.1 Global Nuclear Receptor ROR Gamma Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nuclear Receptor ROR Gamma Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nuclear Receptor ROR Gamma Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nuclear Receptor ROR Gamma Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nuclear Receptor ROR Gamma Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nuclear Receptor ROR Gamma Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nuclear Receptor ROR Gamma Manufacturers, Product Type & Application
  13. 4.7 Global Nuclear Receptor ROR Gamma Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nuclear Receptor ROR Gamma Market CR5 and HHI
  16. 4.8.2 2025 Nuclear Receptor ROR Gamma Tier 1, Tier 2, and Tier 3
5 Nuclear Receptor ROR Gamma Market by Type
  1. 5.1 Global Nuclear Receptor ROR Gamma Revenue by Type
  2. 5.1.1 Global Nuclear Receptor ROR Gamma Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nuclear Receptor ROR Gamma Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nuclear Receptor ROR Gamma Sales by Type
  6. 5.2.1 Global Nuclear Receptor ROR Gamma Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nuclear Receptor ROR Gamma Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nuclear Receptor ROR Gamma Price by Type
6 Nuclear Receptor ROR Gamma Market by Application
  1. 6.1 Global Nuclear Receptor ROR Gamma Revenue by Application
  2. 6.1.1 Global Nuclear Receptor ROR Gamma Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nuclear Receptor ROR Gamma Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nuclear Receptor ROR Gamma Sales by Application
  6. 6.2.1 Global Nuclear Receptor ROR Gamma Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nuclear Receptor ROR Gamma Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nuclear Receptor ROR Gamma Price by Application
7 Company Profiles
  1. 7.1 Eli Lilly
  2. 7.1.1 Eli Lilly Company Information
  3. 7.1.2 Eli Lilly Business Overview
  4. 7.1.3 Eli Lilly Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Eli Lilly Nuclear Receptor ROR Gamma Product Portfolio
  6. 7.1.5 Eli Lilly Recent Developments
  7. 7.2 GlaxoSmithKline Plc
  8. 7.2.1 GlaxoSmithKline Plc Company Information
  9. 7.2.2 GlaxoSmithKline Plc Business Overview
  10. 7.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product Portfolio
  12. 7.2.5 GlaxoSmithKline Plc Recent Developments
  13. 7.3 Biogen Inc
  14. 7.3.1 Biogen Inc Company Information
  15. 7.3.2 Biogen Inc Business Overview
  16. 7.3.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Biogen Inc Nuclear Receptor ROR Gamma Product Portfolio
  18. 7.3.5 Biogen Inc Recent Developments
  19. 7.4 Beijing Hanmi Pharmaceutical
  20. 7.4.1 Beijing Hanmi Pharmaceutical Company Information
  21. 7.4.2 Beijing Hanmi Pharmaceutical Business Overview
  22. 7.4.3 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product Portfolio
  24. 7.4.5 Beijing Hanmi Pharmaceutical Recent Developments
  25. 7.5 Reata Pharmaceuticals Inc
  26. 7.5.1 Reata Pharmaceuticals Inc Company Information
  27. 7.5.2 Reata Pharmaceuticals Inc Business Overview
  28. 7.5.3 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product Portfolio
  30. 7.5.5 Reata Pharmaceuticals Inc Recent Developments
  31. 7.6 Phenex Pharmaceuticals AG
  32. 7.6.1 Phenex Pharmaceuticals AG Company Information
  33. 7.6.2 Phenex Pharmaceuticals AG Business Overview
  34. 7.6.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product Portfolio
  36. 7.6.5 Phenex Pharmaceuticals AG Recent Developments
  37. 7.7 Pfizer Inc
  38. 7.7.1 Pfizer Inc Company Information
  39. 7.7.2 Pfizer Inc Business Overview
  40. 7.7.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Inc Nuclear Receptor ROR Gamma Product Portfolio
  42. 7.7.5 Pfizer Inc Recent Developments
  43. 7.8 Lead Pharma Holding BV
  44. 7.8.1 Lead Pharma Holding BV Company Information
  45. 7.8.2 Lead Pharma Holding BV Business Overview
  46. 7.8.3 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product Portfolio
  48. 7.8.5 Lead Pharma Holding BV Recent Developments
  49. 7.9 Glenmark Pharmaceuticals
  50. 7.9.1 Glenmark Pharmaceuticals Company Information
  51. 7.9.2 Glenmark Pharmaceuticals Business Overview
  52. 7.9.3 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product Portfolio
  54. 7.9.5 Glenmark Pharmaceuticals Recent Developments
  55. 7.10 Genfit SA
  56. 7.10.1 Genfit SA Company Information
  57. 7.10.2 Genfit SA Business Overview
  58. 7.10.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Genfit SA Nuclear Receptor ROR Gamma Product Portfolio
  60. 7.10.5 Genfit SA Recent Developments
  61. 7.11 Eurofins Advinus
  62. 7.11.1 Eurofins Advinus Company Information
  63. 7.11.2 Eurofins Advinus Business Overview
  64. 7.11.3 Eurofins Advinus Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Eurofins Advinus Nuclear Receptor ROR Gamma Product Portfolio
  66. 7.11.5 Eurofins Advinus Recent Developments
  67. 7.12 Celgene Corp
  68. 7.12.1 Celgene Corp Company Information
  69. 7.12.2 Celgene Corp Business Overview
  70. 7.12.3 Celgene Corp Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Celgene Corp Nuclear Receptor ROR Gamma Product Portfolio
  72. 7.12.5 Celgene Corp Recent Developments
  73. 7.13 Bristol-Myers Squibb Company
  74. 7.13.1 Bristol-Myers Squibb Company Company Information
  75. 7.13.2 Bristol-Myers Squibb Company Business Overview
  76. 7.13.3 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product Portfolio
  78. 7.13.5 Bristol-Myers Squibb Company Recent Developments
  79. 7.14 Brickell Biotech Inc
  80. 7.14.1 Brickell Biotech Inc Company Information
  81. 7.14.2 Brickell Biotech Inc Business Overview
  82. 7.14.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Brickell Biotech Inc Nuclear Receptor ROR Gamma Product Portfolio
  84. 7.14.5 Brickell Biotech Inc Recent Developments
  85. 7.15 Aurigene Discovery Technologies
  86. 7.15.1 Aurigene Discovery Technologies Company Information
  87. 7.15.2 Aurigene Discovery Technologies Business Overview
  88. 7.15.3 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product Portfolio
  90. 7.15.5 Aurigene Discovery Technologies Recent Developments
  91. 7.16 AbbVie Inc
  92. 7.16.1 AbbVie Inc Company Information
  93. 7.16.2 AbbVie Inc Business Overview
  94. 7.16.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 AbbVie Inc Nuclear Receptor ROR Gamma Product Portfolio
  96. 7.16.5 AbbVie Inc Recent Developments
8 North America
  1. 8.1 North America Nuclear Receptor ROR Gamma Market Size by Type
  2. 8.1.1 North America Nuclear Receptor ROR Gamma Revenue by Type (2021-2032)
  3. 8.1.2 North America Nuclear Receptor ROR Gamma Sales by Type (2021-2032)
  4. 8.1.3 North America Nuclear Receptor ROR Gamma Price by Type (2021-2032)
  5. 8.2 North America Nuclear Receptor ROR Gamma Market Size by Application
  6. 8.2.1 North America Nuclear Receptor ROR Gamma Revenue by Application (2021-2032)
  7. 8.2.2 North America Nuclear Receptor ROR Gamma Sales by Application (2021-2032)
  8. 8.2.3 North America Nuclear Receptor ROR Gamma Price by Application (2021-2032)
  9. 8.3 North America Nuclear Receptor ROR Gamma Market Size by Country
  10. 8.3.1 North America Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nuclear Receptor ROR Gamma Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nuclear Receptor ROR Gamma Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Nuclear Receptor ROR Gamma Market Size by Type
  2. 9.1.1 Europe Nuclear Receptor ROR Gamma Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nuclear Receptor ROR Gamma Sales by Type (2021-2032)
  4. 9.1.3 Europe Nuclear Receptor ROR Gamma Price by Type (2021-2032)
  5. 9.2 Europe Nuclear Receptor ROR Gamma Market Size by Application
  6. 9.2.1 Europe Nuclear Receptor ROR Gamma Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nuclear Receptor ROR Gamma Sales by Application (2021-2032)
  8. 9.2.3 Europe Nuclear Receptor ROR Gamma Price by Application (2021-2032)
  9. 9.3 Europe Nuclear Receptor ROR Gamma Market Size by Country
  10. 9.3.1 Europe Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nuclear Receptor ROR Gamma Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nuclear Receptor ROR Gamma Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Nuclear Receptor ROR Gamma Market Size by Type
  2. 10.1.1 China Nuclear Receptor ROR Gamma Revenue by Type (2021-2032)
  3. 10.1.2 China Nuclear Receptor ROR Gamma Sales by Type (2021-2032)
  4. 10.1.3 China Nuclear Receptor ROR Gamma Price by Type (2021-2032)
  5. 10.2 China Nuclear Receptor ROR Gamma Market Size by Application
  6. 10.2.1 China Nuclear Receptor ROR Gamma Revenue by Application (2021-2032)
  7. 10.2.2 China Nuclear Receptor ROR Gamma Sales by Application (2021-2032)
  8. 10.2.3 China Nuclear Receptor ROR Gamma Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nuclear Receptor ROR Gamma Market Size by Type
  2. 11.1.1 Asia Nuclear Receptor ROR Gamma Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nuclear Receptor ROR Gamma Sales by Type (2021-2032)
  4. 11.1.3 Asia Nuclear Receptor ROR Gamma Price by Type (2021-2032)
  5. 11.2 Asia Nuclear Receptor ROR Gamma Market Size by Application
  6. 11.2.1 Asia Nuclear Receptor ROR Gamma Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nuclear Receptor ROR Gamma Sales by Application (2021-2032)
  8. 11.2.3 Asia Nuclear Receptor ROR Gamma Price by Application (2021-2032)
  9. 11.3 Asia Nuclear Receptor ROR Gamma Market Size by Country
  10. 11.3.1 Asia Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nuclear Receptor ROR Gamma Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nuclear Receptor ROR Gamma Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nuclear Receptor ROR Gamma Market Size by Type
  2. 12.1.1 SAMEA Nuclear Receptor ROR Gamma Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nuclear Receptor ROR Gamma Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nuclear Receptor ROR Gamma Price by Type (2021-2032)
  5. 12.2 SAMEA Nuclear Receptor ROR Gamma Market Size by Application
  6. 12.2.1 SAMEA Nuclear Receptor ROR Gamma Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nuclear Receptor ROR Gamma Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nuclear Receptor ROR Gamma Price by Application (2021-2032)
  9. 12.3 SAMEA Nuclear Receptor ROR Gamma Market Size by Country
  10. 12.3.1 SAMEA Nuclear Receptor ROR Gamma Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nuclear Receptor ROR Gamma Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nuclear Receptor ROR Gamma Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nuclear Receptor ROR Gamma Value Chain Analysis
  2. 13.1.1 Nuclear Receptor ROR Gamma Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nuclear Receptor ROR Gamma Production Mode & Process
  6. 13.2 Nuclear Receptor ROR Gamma Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nuclear Receptor ROR Gamma Distributors
  9. 13.2.3 Nuclear Receptor ROR Gamma Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst